Evidence map›Paper›PMID 35050148›Full record

ArticleMetabolites2021

The Cholesterol Metabolite Cholest-5-en-3-One Alleviates Hyperglycemia and Hyperinsulinemia in Obese (

Koji Nagao, Nao Inoue, Kunio Suzuki, Takeshi Shimizu, Teruyoshi Yanagita

Open access · goldAbstract read
In one paragraph

Article in Metabolites, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Anti-Obesity and Anti-Hyperglycemic Effects ofInternational journal of molecular sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Koji NagaoDepartment of Biological Resource Science, Saga University, 1 Honjo-machi, Saga 840-8502, Japan.
Nao InoueDepartment of Biological Resource Science, Saga University, 1 Honjo-machi, Saga 840-8502, Japan.
Kunio SuzukiRIKEN Nishina Center, Wako 351-0198, Japan.
Takeshi ShimizuRIKEN Center for Sustainable Resource Science, Wako 351-0198, Japan.
Teruyoshi YanagitaDepartment of Biological Resource Science, Saga University, 1 Honjo-machi, Saga 840-8502, Japan.
Saga University · JPKagoshima University · JPRIKEN Center for Sustainable Resource Science · JPRIKEN Nishina Center · JP

Funding

Japan Society for the Promotion of Science 23580173
6 · The paper itself

Abstract

Dietary sterols are catabolized into various substances in the intestinal tract. Dietary 3-oxo derivatives of cholesterol and plant sterols (e.g., cholest-4-en-3-one and campest-5-en-3-one) have been shown to have anti-obesity effects. In this study, we tested whether feeding cholest-5-en-3-one (5-cholestenone), a cholesterol metabolite, to

Indexed as

5-cholestenonehyperglycemiahyperinsulinemiainflammationobese db/db mouse

Identifiers

PMID35050148
PMCPMC8779233
OpenAlexW4200381767

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.